What this means
This review looks at two brain proteins that help control inhibitory connections between nerve cells. It suggests they may work together in brain aging, but this idea is not yet proven.
Plain-English summary written by an AI model from the abstract. The original is below.
- Who it was tested in
- A narrative review of earlier studies, no new experiments
- Kind of research
- A summary of earlier studies
The science
- Original title
- The potential role of the gephyrin-CNTNAP4 interface in brain aging: Mechanisms of inhibitory circuit dysfunction and cognitive decline.
- Authors
- Baothman A, Faheem SA, Al-Kuraishy HM et al.
- Journal
- Progress in neuro-psychopharmacology & biological psychiatry
- Published
- Oct 15, 2026
- Study type
- Review
- PMID
- 42880581 ↗
Abstract
Brain aging is a multifactorial process characterized by progressive deterioration of synaptic integrity, impaired neuronal connectivity, and cognitive decline. Physiological brain aging involves a natural decline in cognitive function due to reduced synaptic connections, and synaptic integrity. However, the brain maintains plasticity, allowing individuals to adapt through lifelong learning and targeted lifestyle interventions. Conversely, pathological brain aging refers to abnormal, accelerated neurological decline that extends far beyond typical age-related changes, characterized by noteworthy brain atrophy, and is a primary driver of neurodegenerative diseases. Increasing evidence suggests that dysfunction of inhibitory neurotransmission represents a fundamental mechanism underlying age-associated alterations in brain circuitry. Among the molecular determinants governing inhibitory synaptic organization, the gephyrin, a principal postsynaptic scaffold protein, and contactin-associated protein-like 4 (CNTNAP4), a synaptic adhesion molecule involved in neuronal connectivity and neurotransmitter regulation, have independently emerged as important modulators of synaptic homeostasis. However, their potential functional interplay in normal and pathological brain aging remains poorly understood. Therefore, in this narrative review, we examine current knowledge regarding the structural and functional biology of gephyrin and CNTNAP4, emphasizing their contributions to inhibitory synapse maintenance, neuronal network stability, and age-related cognitive function. We further discuss convergent mechanisms through which disturbances in gephyrin-dependent receptor clustering and CNTNAP4-mediated synaptic adhesion may promote excitatory-inhibitory imbalance, synaptic destabilization, and circuit dysfunction during aging. Particular attention is given to shared downstream pathways implicated in brain senescence, including mechanistic target of rapamycin (mTOR) signaling, sirtuin-1 (SIRT1) activity, mitochondrial homeostasis, and neuronal autophagy. We propose the concept of a Gephyrin-CNTNAP4 interface as a previously underappreciated framework linking inhibitory synaptic scaffolding with cell-adhesion mechanisms in the aging brain. Understanding this interface may provide novel insights into the molecular basis of cognitive decline and facilitate the development of multi-target therapeutic strategies to preserve synaptic resilience and promote healthy brain aging.
Baothman A, Faheem SA, Al-Kuraishy HM et al. The potential role of the gephyrin-CNTNAP4 interface in brain aging: Mechanisms of inhibitory circuit dysfunction and cognitive decline. Progress in neuro-psychopharmacology & biological psychiatry. 2026. doi:10.1016/j.pnpbp.2026.111973. PMID: 42880581. https://pubmed.ncbi.nlm.nih.gov/42880581/
See all research on Rapamycin →